EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Defining Bath Ankylosing Spondylitis Disease Activity Index Cut‐off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis

Stylianos Georgiadis iD, Lykke Midtbøll Ørnbjerg iD, Brigitte Michelsen iD, Tore K Kvien iD, Mehrdad Shoae Kazemi iD, Jakub Závada iD, Karel Pavelka iD, Bente Glintborg iD, Anne Gitte Loft iD, Andreas Reich iD, Anne C Regierer iD, Ana Maria Rodrigues iD und 12 weitere

ACR Open Rheumatology · 2025-12 · 7 (12)

DOI: 10.1002/acr2.70125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 02.12.2025. Verfasst von Stylianos Georgiadis und 23 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Gl…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novartis Pharma AG, UCB Biopharma SRL, UCB.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is widely used for assessing disease activity in patients with axial spondyloarthritis (axSpA), particularly in settings where markers of inflammation are unavailable. As no consensus on BASDAI cut‐off values exists for disease activity states in axSpA, we aimed to develop and validate such cut‐offs against external criteria.

Methods

Routine care patients with axSpA initiating a biologic disease‐modifying antirheumatic drug in eight European registries were included. Receiver operating characteristic analyses against external criteria were performed to determine optimal BASDAI values for separating remission, low disease activity (LDA), high disease activity (HDA), and very high disease activity (VHDA). Follow‐up data at 6 months were used to select BASDAI cut‐off values between remission and LDA and between LDA and HDA, whereas baseline data were used to select the cut‐off for VHDA. The level of agreement between disease activity states based on BASDAI and Axial Spondyloarthritis Disease Activity Score (ASDAS) cut‐off values was assessed using the proportion of discordance and weighted kappa.

Results

In this cohort of 4,633 patients, the optimal BASDAI cut‐off values between remission, LDA, HDA and VHDA were estimated to be 4,600 patients. These cut‐off values can be used for assessing disease activity and monitoring patients with axSpA, particularly when laboratory markers are unavailable.

Autor:innen und Institutionen

  • Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
  • COPECARE, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, and Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospi…
  • REMEDY, Diakonhjemmet Hospital, and the University of Oslo, Oslo, Norway.
  • Institute of Rheumatology and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • COPECARE, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics and DANBIO, Rigshospitalet, Glostrup, and the University of Copenhagen, Copenhagen, Denmark.
  • Aarhus University Hospital and Aarhus University, Aarhus, Denmark.

ORCID-Profile: Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Mehrdad Shoae Kazemi, Jakub Závada, Karel Pavelka, Bente Glintborg, Anne Gitte Loft, Andreas Reich, Anne C Regierer, Ana Maria Rodrigues, Maria José Santos, Jarno Rutanen, Laura Kuusalo, Adrian Ciurea, Michael J Nissen, Bjorn Gudbjornsson, Ólafur Pálsson, Žiga Rotar, Katja Perdan Pirkmajer, Daniela Di Giuseppe, Mikkel Østergaard, Merete Lund Hetland

Förderung

  • Novartis Pharma AG
  • UCB Biopharma SRL
  • UCB

Zitieren

APA

Georgiadis, S., Ørnbjerg, L. M., Michelsen, B., Kvien, T. K., Shoae Kazemi, M., Závada, J., Pavelka, K., Glintborg, B., Loft, A. G., Reich, A., Regierer, A. C., Rodrigues, A. M., Santos, M. J., Rutanen, J., Kuusalo, L., Ciurea, A., Nissen, M. J., Gudbjornsson, B., Pálsson, Ó., …, & Hetland, M. L. (2025). Defining Bath Ankylosing Spondylitis Disease Activity Index Cut‐off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis. ACR Open Rheumatology, 7(12). https://doi.org/10.1002/acr2.70125

Vancouver

Georgiadis S, Ørnbjerg LM, Michelsen B, Kvien TK, Shoae Kazemi M, Závada J, et al. Defining Bath Ankylosing Spondylitis Disease Activity Index Cut‐off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis. ACR Open Rheumatology. 2025;7(12). doi:10.1002/acr2.70125

BibTeX
@article{Georgiadis2025,
  author = {Georgiadis, Stylianos and Ørnbjerg, Lykke Midtbøll and Michelsen, Brigitte and Kvien, Tore K and Shoae Kazemi, Mehrdad and Závada, Jakub and Pavelka, Karel and Glintborg, Bente and Loft, Anne Gitte and Reich, Andreas and Regierer, Anne C and Rodrigues, Ana Maria and Santos, Maria José and Rutanen, Jarno and Kuusalo, Laura and Ciurea, Adrian and Nissen, Michael J and Gudbjornsson, Bjorn and Pálsson, Ólafur and Rotar, Žiga and Perdan Pirkmajer, Katja and Di Giuseppe, Daniela and Østergaard, Mikkel and Hetland, Merete Lund},
  title = {Defining Bath Ankylosing Spondylitis Disease Activity Index Cut‐off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis},
  journal = {ACR Open Rheumatology},
  year = {2025},
  volume = {7},
  number = {12},
  doi = {10.1002/acr2.70125}
}
Kostenlos starten →